FDAFDA · Food and drugs·Recall number D-1064-2016
Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612
Published July 13, 2016 · Recall initiated: May 10, 2016
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Allergan Sales, LLC
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: a) 84172, b) 84173, Exp FEB/2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.